Delivery Order SPE2DB20D2104-SPE2DB24FMBCT
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,552.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a completion date of December 16, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $3,211.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a completion date of June 5, 2025. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is...
This federal contract award is a delivery order valued at $2,584.79 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 18, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $16,304.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, and is a firm fixed-price delivery order with a completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $25,573.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $6,301.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $4,726.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $7,752.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,812.86 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $9,475.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a completion date of November 13, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...